STAT3 and ovarian carcinoma: The results demonstrated that compared with stage III-IV ovarian cancer patients, stage I–II ovarian cancer patients had significantly lower STAT3/p-STAT3 expression levels (OR = 0.36, 95% CI = 0.22–0.59, p < 0.00001).